Adipocyte cell number is a crucial factor for controlling of body weight and metabolic function. The regulation of adipocyte numbers in the adult organism is not fully understood but is considered to depend on the homeostasis of cell differentiation and apoptosis. Herein, we show that targeted deletion of the activator protein (AP-1)-related transcription factor Fra-2 in adipocytes in vivo (Fra-2
Adipocyte cell number is a crucial factor for controlling of body weight and metabolic function. The regulation of adipocyte numbers in the adult organism is not fully understood but is considered to depend on the homeostasis of cell differentiation and apoptosis. Herein, we show that targeted deletion of the activator protein (AP-1)-related transcription factor Fra-2 in adipocytes in vivo (Fra-2 Dadip mice) induces a high-turnover phenotype with increased differentiation and apoptosis of adipocytes, leading to a decrease in body weight and fat pad mass. Importantly, adipocyte cell numbers were significantly reduced in Fra-2 Dadip mice. At the molecular level, Fra-2 directly binds to the PPARc2 promoter and represses PPARc2 expression. Deletion of Fra-2 leads to increased PPARc2 expression and adipocyte differentiation as well as increased adipocyte apoptosis through upregulation of hypoxia-inducible factors (HIFs). These findings suggest that Fra-2 is an important checkpoint to control adipocyte turnover. Therefore, inhibition of Fra-2 may emerge as a useful strategy to increase adipocyte turnover and to reduce adipocyte numbers and fat mass in the body. Alterations in adipose tissue lead to severe metabolic disturbances. During obesity, white adipose tissue expansion is based on both cellular hypertrophy (an increase in adipocyte volume) and hyperplasia (an increase in adipocyte cell number). White adipose tissue becomes hypoxic during obesity that leads to adipose tissue dysfunction. 1 The response of most cells to hypoxia is to induce a program of gene expression that is regulated by hypoxia-inducible factors (HIFs), basic helix-loop-helix/PAS transcription factors consisting of a a-subunit (HIF1a) and a b-subunit (HIF1b). 2 HIF target genes are involved in several physiological processes such as angiogenesis, glucose metabolism and cell survival. 3 In accordance, targeted deletion of HIF1a in adipocytes has an impact on dietary obesity and associated pathologies such as glucose intolerance. 4, 5 However, the role of HIFs during adipocyte differentiation and survival remains defined incompletely to date. Moreover, despite that adipocyte hypertrophy prevails in obesity, the adipocyte number variation in adult age remains under debate. 1 Apoptosis is a normal phenomenon of cell death for the purpose of maintaining homeostasis. The apoptotic molecular machinery such as the mitochondrial and the caspase pathways are present in adipocyte and not different from other cells. It is reported that several adipokines play roles in induction of adipocyte apoptosis. 6 However, the question remains of how apoptosis is regulated in adipocytes at the cellular and molecular levels.
Mesenchymal stem cells (MSCs) can differentiate into adipocytes following the induction of lineage-specific transcription factors C/EBPb (CCAAT/enhancer binding protein-b) that induce the expression of PPARg2 (peroxisome proliferator-activated receptor-g2) and C/EBPa controlling the late stages of adipogenesis. 7 Another transcription factor family that can influence adipocyte commitment is the activator protein-1 (AP-1) transcription factor complex. This complex consists of a variety of dimers composed of members of the Fos, Jun and activating transcription factor (ATF) families. 8 Analyses of mice genetically modified for Fos proteins have underlined the important functions of Fos in osteoblast and adipocyte differentiation. 8 Mice overexpressing Fos-related antigen 1 (Fra-1) or the short isoform of FosB (DFosB) show impaired adipocyte differentiation 9-11 but enhanced osteoblast differentiation. [12] [13] [14] Interestingly, the second Fra family member, Fos-related antigen 2 (Fra-2), regulates bone mass via affecting HIF expression. Thus, mice overexpressing Fra-2 develop an osteosclerotic phenotype, whereas the absence of Fra-2 leads to a defect of osteoblast differentiation 15 and a giant osteoclast phenotype induced by the activation of HIF1a. 16 Furthermore, leptin is a transcriptional target of Fra-2, 17 suggesting that Fra-2 may indeed represent an important transcription factor for adipocytes. Herein, we show that Fra-2 deletion in adipocytes affects body and fat pad mass by the regulation of adipocyte number. Mechanistically, Fra-2 regulates transcriptionally PPARg2 expression and adipocyte survival by the modulation of HIF expression.
Results
Inducible adipocyte-specific deletion of Fra-2. To obtain functional data for a role of Fra-2 in the adipose tissue, we generated adipocyte-specific Fra-2 knockout mice. Mice with the Fabp4-CreERT allele were crossed with mice carrying Fra-2 floxed alleles to delete Fra-2 in adipocytes (Fra-2 Dadip ). As Fabp4-CreERT is a tamoxifen-inducible line, we were able to analyze the role of Fra-2 inactivation in adult mice. Injection of tamoxifen was performed at the age of 6 weeks and the analyses were performed 6 weeks later. Immunohistochemical (IHC) staining for Fra-2 of fat tissues showed decreased Fra-2 expression in adipocytes of white and brown adipose tissue, whereas no decrease in expression was found in the spleen (Supplementary Figure 1A) . Furthermore, only very low levels of Fra-2 mRNA were expressed in the white and brown adipose tissue of Fra-2
Dadip mice (Supplementary Figure 1B) , whereas its expression in liver, muscle, spleen and lung was equal to wild-type littermate controls (Supplementary Figure 1B) . These results indicate that Fra-2 deletion in Fra-2
Dadip mice is specific to the adipose tissue.
Fra-2 deletion in adipocytes decreases body and fat pad weight. We first assessed body and fat pad weight in Fra-2 wild-type and mutant mice. Total body weight and percentage of body fat were significantly decreased in Fra-2
Dadip mice compared with wild-type controls in conditions of normal diet (ND) (Figure 1a) . Similarly, the ratio of fat pad weight to body weight was significantly lower in Fra-2
Dadip mice than in controls (Figure 1b ). When mice were fed a high-fat diet (HFD) for a period of 6 weeks for inducing obesity, similar changes were observed: Fra-2 Dadip mice showed significantly lower body weight and fat pad weight than wild-type controls (Figures 1a and b) .
Low adipocyte number but increased adipocyte size in Fra-2 Dadip mice. Further histological analyses of the fat pads of Fra-2
Dadip mice and respective controls showed that white adipocyte cell number was significantly decreased in Fra-2
Dadip mice compared with controls when mice received ND (Figures 1c and d) . Furthermore, analysis of adipocyte cell size showed a significant increase in cell size despite smaller cell number in Fra-2
Dadip compared with controls (Figures 1c and d) . HFD increased adipocyte size in both mutant and wild-type mice, reflecting hypertrophy of adipocytes that was significantly more pronounced in Fra-2 mutants than controls (Figures 1c and d) .
Increased adipocyte apoptosis in Fra-2 Dadip mice. To better understand the molecular mechanisms behind the fat phenotype observed in Fra-2
Dadip mice and to determine why adipocyte numbers are low in Fra-2 mutants, we analyzed the proliferation and the apoptosis status of the fat pad. No differences could be detected in proliferation of adipocyte as assessed by Ki67 staining (data not shown). However, apoptosis assessed by TUNEL assay, annexin V flow cytometry, cleaved caspase 3 staining and western blot revealed an increased rate of apoptosis in the fat pad of Fra-2
Dadip mice (Figures 2a and b and Supplementary  Figure 2A ), suggesting that low fat pad mass and low adipocyte numbers in Fra-2
Dadip mice depend on increased adipocyte apoptosis.
Increased hypoxia and HIF activation in adipose tissue of Fra-2 Dadip mice. Our previous finding showing that Fra-2 is involved in the regulation of osteoclast apoptosis and that this effect depends on HIF1a activation 16 prompted us to investigate whether the increased apoptosis in Fra-2 Figure 2B and Figure 2c ). In addition, the molecular analyses of HIFs by quantitative PCR (qPCR) revealed increased expression of HIF1a and HIF2a in Fra-2
Dadip fat pad, whereas no differences in HIF1b levels were detected ( Figure 2d ). Moreover, expression of several HIF target genes such as Glut1 (glucose transporter), Inos (nitric oxide synthase), Vegfa (vascular endothelial growth factor a) and BNIP3 (BCL2/adenovirus E1B 19 kDa proteininteracting protein 3) was increased in Fra-2
Dadip fat pads, whereas others such as Bcl2 (B-cell lymphoma 2) and BNIP3L (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like) were not altered ( Figure 2e ). These findings support the concept that Fra-2 regulates hypoxia and HIF expression in the adipose tissue that affects adipocyte numbers and fat pad size via regulation of apoptosis.
Hypoxia drives expression of HIFs and apoptosis-related genes in adipocytes. In order to determine whether hypoxia could induce apoptosis in a cell autonomous manner, adipocytes isolated from fat pads were placed in hypoxic chambers and analyzed for HIFs and HIF target gene expression. In addition, expression of apoptosis-related genes was analyzed. As shown in Figures 3a and b, HIF1a, HIF2a and their target genes Inos and BNIP3 were increased in adipocytes placed in hypoxic chambers for 24 h. Moreover, Bad (Bcl-2-associated death promoter) and Bax (Bcl-2-associated X protein) mRNA levels in adipocytes increased within 12 h of hypoxia (Figure 3c ), suggesting that hypoxic conditions lead to an imbalance of the Bcl-2 family in favor of the apoptotic pathway.
To determine whether apoptosis was dependent on the Bcl-2 family, overexpressing plasmids for B-cell lymphoma-extra large (Bcl-xl) were transfected in primary adipocyte exposed to normoxia or hypoxia 1% for 24 h. The annexin V flow cytometry analyses revealed increased apoptosis in adipocyte culture under hypoxia that can be rescued by the overexpression of Bcl-xl (Figure 3d ), suggesting that the apoptosis induced by hypoxia in adipocytes is dependent on the Bcl-2 family.
Fra-2 regulates HIFs in the adipocyte in a cell autonomous manner. In order to determine whether Fra-2 affects HIF expression in adipocytes, we analyzed HIF expression and HIF target gene expression on adipocytederived stem cells isolated from fat pads of Fra-2
Dadip and wild-type controls. Interestingly, HIF1a, HIF2a and their targets Vegfa and BNIP3 were significantly increased in the Fra-2
Dadip cultures at day 7 of differentiation ( Figure 3e ). These data suggest that Fra-2 deletion leads to increased HIFs and HIF target gene expression in the adipose tissue in vivo and in vitro.
In order to determine whether apoptosis induced by hypoxia was dependent on HIF1a or HIF2a or both, knockdown of HIF1a and HIF2a was performed in vitro by transfection of primary cells isolated from Fra-2
Dadip and control fat pads. Interestingly, the knockdown of HIF1a or HIF2a was able to rescue the increased level of apoptosis observed in Fra-2 Dadip adipocyte cultures under hypoxic conditions (Figure 3f) . Moreover, to determine whether similar observations could be found in vivo, i.p. and hydrodynamic injections of shRNA against HIF1a or HIF 2a were performed in Fra-2
Dadip and littermate control mice. Interestingly, in wild-type condition, the knockdown of HIF1a and HIF2a was able to decrease the basal level of apoptosis in perigonadal fat tissue (Figure 3g ). In addition, no difference in apoptosis could be detected anymore in Fra-2
Dadip and littermate control perigonadal fat after knockdown of HIF1a or HIF2a (Figure 3g ), suggesting that HIF1a and HIF2a regulate apoptosis in white adipose tissue.
Increased PPARc2 expression as the link between Fra-2 and HIF. To explain the molecular mechanisms of how Fra-2 regulates HIFs, we checked for differences in the regulation of genes involved in adipocyte differentiation among Fra-2
Dadip mice and controls. In vivo, no significant changes could be detected in the expression of C/ebpb, C/ebpa, C/ebpd, Glut4, PPARa, PPARg1, adiponectin and resistin (Supplementary Figure 2C and D) . Interestingly, increase in mRNA levels of PPARg total and PPARg2 as well as Fabp4 (fatty acid binding protein 4) was observed in the fat pad from Fra-2
Dadip mice fed ND and HFD as compared with respective wild-type littermate controls (Figure 4a and Supplementary Figure 2C) . IHC analysis for PPARg expression confirmed its upregulation at the protein levels (Supplementary Figure 2E) .
To determine whether the same phenotype could be observed in another white adipose tissue, subcutaneous fat from Fra-2
Dadip and wild-type littermate control mice was analyzed. Indeed, similar phenotype, with increased adipocyte size, increased apoptosis, increased hypoxic markers and increased Fabp4 and PPARg2 mRNA levels, was observed in the subcutaneous white fat from Fra-2 Dadip mice when compared with littermate controls ( Supplementary  Figure 3) , suggesting a common pathway in different white fat tissues. Next, adipocyte differentiation and markers were analyzed when adipocyte stem cells from Fra-2
Dadip mice and respective controls were isolated from the fat pad and differentiated in vitro. Whereas C/ebpa, C/ebpa C/ebpd and PPARg1 were not different among cells from mutant and control mice, the mRNA expression of Fra-2 was decreased and mRNA expression of adiponectin, Fabp4, total PPARg, and PPARg2 was significantly increased in Fra-2
Dadip cells at day 7 of differentiation (Supplementary Figure 4 and Figure 4b ). In addition, cell differentiation was significantly increased in Fra-2
Dadip cultures compared with controls, potentially explaining the increased adipocyte size observed in Fra-2 Dadip mice (Figure 4c ).
To determine whether PPARg2 can regulate HIFs in adipocytes, inhibition of PPARg2 activity by BADGE was performed (Figure 4d ). Treatment with BADGE not only led to a decrease of the adipocyte marker Fabp4 (Figure 4d ), we reasoned that PPARg2 was the key gene regulated by Fra-2 in adipocytes. We therefore assessed Fra-2 binding to the PPARg2 promoter by chromatin immunoprecipitation (ChIP) analysis in 3T3L1 cell lines treated with insulin for 24 h. As shown in Figure 5a , specific primer pairs were used to amplify DNA fragments containing the AP-1 consensus TRE element. Fos and Jun binding to the PPARg2 promoter was observed in two potential sites (Figure 5a and Supplementary Figure 5A) . Interestingly, at the sites À 163/ À 78 bp, the binding of Fra-2 and Fra-1 is increased after insulin treatment (Figure 5a ), suggesting that Fra-2 can bind the PPARg2 promoter and regulate its expression following insulin treatment.
Moreover, in DNA co-transfection experiments, Fra-2 expression vector decreased the activity of a luciferase reporter containing the human PPARg2 promoter fragment including the two sites À 163/ À 78 bp (Figure 5b) . In contrast, an increase in the luciferase activity could be detected when DNA co-transfection experiments were performed with PPARg1 promoter fragment (Figure 5b ). These findings, together with the altered expression of PPARg2 in Fra-2 Dadip mutants, indicate that PPARg2 is a direct transcriptional target of Fra-2.
Fra-2 and PPARc2 can regulate HIFs and vice versa. In order to determine whether HIF1a and HIF2a could be transcriptionally regulated by Fra-2, we performed ChIP analysis in 3T3L1, on AP-1 consensus elements found in both promoters. Interestingly we could find that Fra-2 was able to bind the HIF1a promoter at two putative TRE sequences, À 3105/ À 3066 and À 1220 bp, before the starting codon (Figure 5c ), whereas no binding of Fra-2 could be detected on the HIF2a promoter (Figure 5d ), suggesting a direct transcriptional activation of HIF1a by Fra-2.
To understand how HIF2a can be regulated, we performed the ChIP for PPARg on the previously analyzed sequences. No PPARg binding could be detected on HIF1a promoter (Supplementary Figure 5B) . Surprisingly PPARg could bind the HIF2a promoter at the site À 937 bp (Supplementary Figure 5C) . These results suggest that Fra-2 and PPARg can regulate HIF1a and HIF2a respectively.
To determine whether HIFs can regulate Fra-2 as a retrocontrol mechanism, its mRNA levels were analyzed in 3T3L1 cells exposed to hypoxia. Interestingly, Fra-2 mRNA level was upregulated in 3T3L1 cell culture in hypoxic conditions (Supplementary Figure 6) , suggesting a compensatory mechanism on Fra-2 induced by hypoxia in adipocytes.
Discussion
The results presented in this study reveal a novel function of Fra-2/AP-1 in adipocytes, that is, to regulate fat pad mass and adipocyte number. Mechanistically, Fra-2 inhibits the expression of PPARg2, a key regulator of adipocyte differentiation and homeostasis. By repressing PPARg2, Fra-2 also represses HIFs that control hypoxia and adipocyte survival (see scheme in Figure 5e ). The control of adipocyte numbers has been a matter of uncertainty since many years. 1 Here we found a new pathway that is able to determine adipocyte number in adult age by the regulation of Fra-2 and HIFs. It can be hypothesized that the regulation of the balance between adipocyte differentiation and death determines adipocyte numbers in the fat tissue. Differentiation of mesenchymal cells into adipocytes involves a cascade of transcription factors such as C/EBPa and C/EBPa that in turn activate PPARg, an essential gene for the activation of several adipocyte-specific genes. 19 In addition, AP-1 proteins, such as Fra-1 and DFosB, have also been shown to regulate adipogenesis through C/EBPa or C/EBPb expression respectively, thereby decreasing adipocyte differentiation. 10, 11 Moreover, Fra-2 was shown to regulate leptin expression in adipocytes and osteocalcin in osteoblasts, both of which are involved in the control of body weight and fat distribution. 15, 17 By using Fabp4-CreERT tamoxifen-inducible line, we were able to analyze the role of Fra-2 inactivation in adult mice. The Fabp4-Cre lines were known to potentially have recombination in nonendothelial and nonmyocyte cells in the skeletal muscle. 20 Despite no difference in Fra-2 levels in other organs in the mutant mice, we could not exclude indirect effects induced by unwanted deletion. However, our biochemistry and in vitro culture studies directly link Fra-2 expression to adipogenesis by the transcriptional inhibition of PPARg2 expression.
PPARg2 is not only a master regulator of adipogenesis, but can also display a role in apoptotic signal transduction in adipocytes. 6 Adipocytes express several molecules of the intrinsic and extrinsic apoptotic pathways. An excess of apoptosis can lead to lipodystrophic metabolic changes. 21 However, induction of moderate amounts of adipocyte apoptosis in obese mice has shown metabolic improvement, 22 suggesting that modulation of fat homeostasis by regulating differentiation and apoptosis might represent an instrument for controlling fat pad mass in the body. Interestingly, PPARg can have proapoptotic functions in adipocytes. Thus, PPARg is directly involved in the leptin-induced adipocyte apoptosis signal pathway. 23 Our observation that increased PPARg expression in the absence of Fra-2 not only enhanced adipocyte differentiation but also apoptosis support this concept.
During hypoxia and induction of HIF1a, an intricate balance exists between factors that induce or counteract apoptosis. Previous studies of gain and loss of function of HIF1a in adipocytes have revealed its role during adipocyte differentiation and diabetes. 24, 25 In addition, HIF2a, which has independent functions of HIF1a, increases during adipogenesis in vitro, indicating that its upregulation is necessary for execution of adipogenesis and maintenance of mature adipocyte functions. 26 Our results confirmed that increased HIF1a and HIF2a expression correlated with a cell-autonomous increase of adipocyte differentiation. In addition, we show that hypoxia and increased HIF expression induced adipocyte apoptosis that was dependent on Bcl-xl. Notably, HIF1a can directly be regulated by Fra-2 and HIF2a expression that, in turn, is directly regulated by PPARg, providing a link between adipocyte differentiation and apoptosis. Moreover, the alteration of Fra-2 expression by hypoxia as a feedback loop provides further insight into the regulation of adipocyte turnover.
In summary, our data add a new role of Fra-2 in adipose tissue homeostasis by regulating PPARg2 and HIF expression. Modulation of Fra-2 expression in mesenchymal cells may emerge as potent tool to control adipocyte number in the body and may open new avenues to manage obesity and metabolic disease.
Materials and Methods
Mice. The generation of Fra-2 floxed mice is described elsewhere. 27, 28 Fabp4-CreERT mice were described previously. 29 All mice were maintained on a mixed 129/C57Bl6 background. Littermate mice were used as controls in this study. Genotyping primers were as follows: Fra-2 lox forward: 5 0 -GAGGGAGTTGGGGAT AGAGTGGTA-3 0 , Fra-2 lox reverse: 5 0 -GGACAGCAGGTCAGGAGTAGATGA-3 0 , Cre forward: 5 0 -CCAGAGACGGAAATCCATCGCTCG-3 0 and Cre reverse: 5 0 -CGG TCGATGCAACGAGTGATGAGG-3 0 . To delete Fra-2 in vivo, mutant and control mice were injected intraperitoneally with 1 mg tamoxifen (Sigma-Aldrich Chemie GmbH, München, Germany) for 5 consecutive days.
Intraperitoneal and hydrodynamic injection of shRNA HIFs. To downregulate the expression of HIF1a and HIF2 a in vivo, intraperitoneal and hydrodynamic intravenous injections were performed with 200 ml or 1ml respectively with shRNA-HIF1 or shRNA-HIF2. After 24 h for the i.p. experiment and 72 h for the hydrodynamic experiment, mice were killed and fat pad adipocytes apoptosis was analyzed.
Histological analysis and immunohistochemistry. Mice were killed by CO 2 asphyxia and tissues were fixed in 3.7% PBS-buffered formaldehyde. For histological analysis, tissues were embedded in paraffin. Then, 5 mm sections of white adipose tissue and 1 mm sections of brown adipose tissue and spleen were used for histological analyses.
Immunohistochemical stainings for Fra-2, HIF1a, HIF2a (Abcam plc, Cambridge, UK), cleaved Caspase 3 (Cell Signaling Technology, Inc., Danvers, MA, USA) and PPARg (Santa Cruz Biotechnology, Inc., Dallas, TX, USA) were performed on deparaffinized sections using Proteinase K as unmasking solution and according to the manufacturer's instructions for the Vectastain KIT (Vector Laboratories, Inc., Burlingame, CA, USA). TUNEL assay was performed according to the manufacturer's instructions using the In Situ cell death Detection kit (Roche Diagnostics Deutschland GmbH, Mannheim, Germany) . Fluorescein is detected by anti-fluorescein antibody Fab fragments from sheep, conjugated with horseradish peroxidase (POD) (Roche Diagnostics Deutschland GmbH) and detected by DAB (Dako, Hamburg, Germany).
Apoptosis analyses by flow cytometry. Apoptosis and necrosis were quantified in adipocytes isolated from fat pad tissue, by Annexin V-FITC (Invitrogen, Life Technologies GmbH, Darmstadt, Germany) staining in the presence of TO-PRO-3 Iodide (Invitrogen). Adipocytes were incubated for 20 min at room temperature with 200 ml Annexin V-FITC in Annexin-binding buffer, washed and resuspended in 200 ml Annexin-binding buffer together with TO-PRO-3 Iodide and measured by flow cytometry.
Hypoxia analysis. Hypoxia stainings were performed using the hypoxyKit (Chemicon, Millipore, Billerica, MA, USA) according to the manufacturer's instructions.
RNA isolation and reverse transcription. Total RNA was isolated with the TRIzol or TriFast protocol (Invitrogen and Peqlab Biotechnologie GmbH, Erlangen, Germany, respectively). cDNA synthesis was performed using 0.50-2 mg RNA with the cDNA Reagents from Applied Biosystems (Life Technologies GmbH).
Real-time PCR analyses. The qPCR reactions were performed using SYBR Green (Eurogentec Deutschland GmbH, Kö ln, Germany). Primers for genes analyses and primers for ChIP analyses used for real-time PCR are available upon request. The comparative CT method was used to quantify the amplified fragments. RNA expression levels were analyzed in duplicate and normalized to actin as housekeeping gene, whereas chromatin-bound fragments were normalized to the same fragments amplified from input chromatin.
Cell culture. The adipogenic cells were generated by culturing adipocyte stem cells isolated from fat pad tissue. Fra-2 deletion in vitro was induced by treating the cells with 3 mg/ml tamoxifen for 2 days. Adipocyte differentiation was induced by addition of 5 mg/ml insulin, 1 mM dexamethasone and 500 mM 3-isobutyl-1-methylxanthine (IBMX) to the confluent cultures.
Adipocyte stem cells isolated from fat pad tissue were cultured in 12-well plates until 70-80% of density. Cells where transfected with 1 mg of shRNA HIF1a, shRNA HIF2a or overexpressing Bcl-xl plasmid diluted in the appropriate amount of Lipofectamine Reagent (Invitrogen). The transfected cells were incubated at 37 1C and 5% of CO 2 . After 48 h, cells were placed in hypoxic chambers (1% O 2 ) for 24 h.
In 'hypoxic' experiments, cells were placed in hypoxic chambers (1% O 2 ) for 24 h. In experiments using BADGE (Sigma), inhibitor of PPARg, the cells were treated with the adipogenic cocktail containing 100 mM BAGDE for 7 days. Medium was changed daily. Isolation of RNA and staining with Oil Red O was performed on day 0 (confluency) and day 7 after stimulation.
Oil Red O staining. Cells were fixed in 3.7% PBS-buffered formaldehyde for 1 h. Cells were stained with Oil Red O solution (0.3% Oil Red O in 60% isopropanol) for 2 h.
